VZ
32
-2
VNO
52
-8
LNC
39
-6
XOM
42
5
FOX
51
9
MAC
67
2
HES
62
4
IR
57
2
LRCX
43
-2
WFC
66
-5
L
47
-5
FSLR
63
6
KEY
33
-4
MMC
57
4
EXPE
74
2
GPC
29
7
STT
60
7
VFC
65
2
RIG
60
5
MOS
48
6
VZ
32
-2
VNO
52
-8
LNC
39
-6
XOM
42
5
FOX
51
9
MAC
67
2
HES
62
4
IR
57
2
LRCX
43
-2
WFC
66
-5
L
47
-5
FSLR
63
6
KEY
33
-4
MMC
57
4
EXPE
74
2
GPC
29
7
STT
60
7
VFC
65
2
RIG
60
5
MOS
48
6
Financhill
Back

Arrowhead Pharmaceuticals 10K Form

Sell
39

ARWR
Arrowhead Pharmaceuticals

Last Price:
20.06
Seasonality Move:
80.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARWR News And Ratings

See the #1 stock for the next 7 days that we like better than ARWR

ARWR Financial Statistics

Sales & Book Value

Annual Sales: $240.74M
Cash Flow: $-129.87M
Price / Cash Flow: 0
Annual Sales: $2.66
Price / Book: 7.54

Profitability

EPS (TTM): -4.66000
Net Income (TTM): $-538.64M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Arrowhead Pharmaceuticals Earnings Forecast

Key Arrowhead Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 20 years for ARWR is 0.00%.
  • The Selling, General & Administrative Expenses for ARWR have been equal to 37.77% of Gross Profit Margin.
  • The Research & Development expenses have been 146.71% of Revenue.
  • The Interest Expense is -8.93% of Operating Income.
  • The Net Earning history of ARWR is -85.27% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 12 years.

Arrowhead Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARWR
CUSIP: 04280A
Website: arrowheadpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARWR Technical Analysis vs Fundamental Analysis

Sell
39
Arrowhead Pharmaceuticals (ARWR) is a Sell

Is Arrowhead Pharmaceuticals a Buy or a Sell?